+64.6%
EMR vs CVE
+72.1%
-7.5%
-29.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -1.3% | +3.0% | +2.0% |
| 7D | -1.5% | +2.5% | -4.0% | -2.1% |
| 30D | -5.6% | +16.7% | -22.4% | -8.9% |
| 3M | +7.9% | +9.3% | -1.3% | +5.4% |
| 6M | +6.0% | +43.6% | -37.6% | -6.2% |
| YTD | +16.4% | +93.6% | -77.1% | -7.2% |
| 1Y | +16.6% | +98.8% | -82.1% | -8.5% |
| All | +64.6% | +72.1% | -7.5% | +28.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling